Vitamin D in the older population: a consensus statement.
Aging
Older people
Vitamin D
Vitamin D deficiency
Vitamin D supplementation
Journal
Endocrine
ISSN: 1559-0100
Titre abrégé: Endocrine
Pays: United States
ID NLM: 9434444
Informations de publication
Date de publication:
01 2023
01 2023
Historique:
received:
17
07
2022
accepted:
21
09
2022
pubmed:
27
10
2022
medline:
7
1
2023
entrez:
26
10
2022
Statut:
ppublish
Résumé
This paper reports results from the 5th International Conference "Controversies in Vitamin D" that was held in Stresa, Italy, 15-18 September 2021. The conference is part of this series that started in 2017 and has been conducted annually since. The objective of these conferences is to identify timely and controversial topics related to Vitamin D. Dissemination of the results of the conference through publications in peer-reviewed journals is an important means by which the most up to date information can be shared with physicians, investigators, and other health care professionals. Vitamin D and aging, the subject of this paper was featured at the conference. Participants were selected to review available literature on assigned topics related to vitamin D and aging and to present their findings with illustrative material, the intent of which was to stimulate discussion and to arrive at a consensus. The presentations were directed towards the following areas: impact of aging on vitamin D production and levels; skeletal effects of vitamin D deficiency in the older population; falls and vitamin D in the aging; potential extra skeletal effects of vitamin D; and strategies to prevent vitamin D deficiency. A final topic was related to how vitamin D might influence the efficacy of vaccines for Covid-19. Hypovitaminosis D can lead to several skeletal and extra-skeletal outcomes. Older adults are at risk for vitamin D deficiency as both production and metabolism of vitamin D change with aging due to factors, such as reduced sun exposure and reduced production capacity of the skin. Skeletal consequences of these age-related changes can include reduced bone mineral density, osteomalacia and fractures. Potential extra-skeletal effects can include added risks for falls, reduced muscle strength, diabetes, cancer, and cardiovascular disease. Strategies to avoid these vitamin D deficiency-related negative outcomes include sun exposure, food fortification, and supplementation. While aging does not diminish sufficient reserve capacity for cutaneous vitamin D production, concerns about skin cancers and practical matters for the institutionalized elderly limit this option. Supplementation with vitamin D is the best option either pharmacologically or through food fortification. Regardless of treatment strategies, interventions to restore sufficient vitamin D status will show positive results only in those who are truly deficient. Thus, treatment goals should focus on avoiding 25(OH)D serum levels <30 nmol/l, with a goal to reach levels >50 nmol/l. The results of this conference has led to consensus on several issues. Vitamin D supplementation should be combined with calcium to reduce fractures in the older population. The goal for adequate Vitamin D status should be to reach a serum level of 25(OH)D >50 nmol/l. It appears that daily low-dose vitamin D regimens reduce the risk of falling, especially in the elderly, compared with infrequent, large bolus doses that may increase it. The role of Vitamin D supplementation on muscle strength remains to be clarified. On the other hand, supplementation decreases the risk of progression to T2D from prediabetes among those who are Vitamin Ddeficient. Of three possible strategies to establish vitamin D sufficiency - sunshine exposure, food fortification, and supplementation - the latter seems to be the most effective and practical in the aging population.
Sections du résumé
BACKGROUND
This paper reports results from the 5th International Conference "Controversies in Vitamin D" that was held in Stresa, Italy, 15-18 September 2021. The conference is part of this series that started in 2017 and has been conducted annually since. The objective of these conferences is to identify timely and controversial topics related to Vitamin D. Dissemination of the results of the conference through publications in peer-reviewed journals is an important means by which the most up to date information can be shared with physicians, investigators, and other health care professionals. Vitamin D and aging, the subject of this paper was featured at the conference.
METHODS
Participants were selected to review available literature on assigned topics related to vitamin D and aging and to present their findings with illustrative material, the intent of which was to stimulate discussion and to arrive at a consensus. The presentations were directed towards the following areas: impact of aging on vitamin D production and levels; skeletal effects of vitamin D deficiency in the older population; falls and vitamin D in the aging; potential extra skeletal effects of vitamin D; and strategies to prevent vitamin D deficiency. A final topic was related to how vitamin D might influence the efficacy of vaccines for Covid-19.
RESULTS
Hypovitaminosis D can lead to several skeletal and extra-skeletal outcomes. Older adults are at risk for vitamin D deficiency as both production and metabolism of vitamin D change with aging due to factors, such as reduced sun exposure and reduced production capacity of the skin. Skeletal consequences of these age-related changes can include reduced bone mineral density, osteomalacia and fractures. Potential extra-skeletal effects can include added risks for falls, reduced muscle strength, diabetes, cancer, and cardiovascular disease. Strategies to avoid these vitamin D deficiency-related negative outcomes include sun exposure, food fortification, and supplementation. While aging does not diminish sufficient reserve capacity for cutaneous vitamin D production, concerns about skin cancers and practical matters for the institutionalized elderly limit this option. Supplementation with vitamin D is the best option either pharmacologically or through food fortification. Regardless of treatment strategies, interventions to restore sufficient vitamin D status will show positive results only in those who are truly deficient. Thus, treatment goals should focus on avoiding 25(OH)D serum levels <30 nmol/l, with a goal to reach levels >50 nmol/l.
CONCLUSIONS
The results of this conference has led to consensus on several issues. Vitamin D supplementation should be combined with calcium to reduce fractures in the older population. The goal for adequate Vitamin D status should be to reach a serum level of 25(OH)D >50 nmol/l. It appears that daily low-dose vitamin D regimens reduce the risk of falling, especially in the elderly, compared with infrequent, large bolus doses that may increase it. The role of Vitamin D supplementation on muscle strength remains to be clarified. On the other hand, supplementation decreases the risk of progression to T2D from prediabetes among those who are Vitamin Ddeficient. Of three possible strategies to establish vitamin D sufficiency - sunshine exposure, food fortification, and supplementation - the latter seems to be the most effective and practical in the aging population.
Identifiants
pubmed: 36287374
doi: 10.1007/s12020-022-03208-3
pii: 10.1007/s12020-022-03208-3
pmc: PMC9607753
doi:
Substances chimiques
Vitamin D
1406-16-2
COVID-19 Vaccines
0
Vitamins
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
31-44Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
A. Giustina, R.A. Adler, N. Binkley, R. Bouillon, P.R. Ebeling, M. Lazaretti-Castro, C. Marcocci, R. Rizzoli, C.T. Sempos, J.P. Bilezikian, Controversies in Vitamin D: summary statement from an international conference. J. Clin. Endocrinol. Metab. 104, 234–240 (2019). https://doi.org/10.1210/jc.2018-01414
doi: 10.1210/jc.2018-01414
C.T. Sempos, A.C. Heijboer, D.D. Bikle, J. Bollerslev, R. Bouillon, P.M. Brannon, H.F. DeLuca, G. Jones, C.F. Munns, J.P. Bilezikian, A. Giustina, N. Binkley, Vitamin D assays and the definition of hypovitaminosis D: Results from the first international conference on controversies in vitamin D. Br. J. Clin. Pharmacol. 84, 2194–2207 (2018). https://doi.org/10.1111/bcp.13652
doi: 10.1111/bcp.13652
P.R. Ebeling, R.A. Adler, G. Jones, U.A. Liberman, G. Mazziotti, S. Minisola, C.F. Munns, N. Napoli, A.G. Pittas, A. Giustina, J.P. Bilezikian, R. Rizzoli, Management of endocrine disease: Therapeutics of vitamin D. Eur. J. Endocrinol. 179, R239–R259 (2018). https://doi.org/10.1530/EJE-18-0151
doi: 10.1530/EJE-18-0151
R. Bouillon, C. Marcocci, G. Carmeliet, D. Bikle, J.H. White, B. Dawson-Hughes, P. Lips, C.F. Munns, M. Lazaretti-Castro, A. Giustina, J. Bilezikian, Skeletal and extraskeletal actions of vitamin D: Current evidence and outstanding questions. Endocr. Rev. 40, 1109–1151 (2019). https://doi.org/10.1210/er.2018-00126
doi: 10.1210/er.2018-00126
A. Giustina, R.A. Adler, N. Binkley, J. Bollerslev, R. Bouillon, B. Dawson-Hughes, P.R. Ebeling, D. Feldman, A.M. Formenti, M. Lazaretti-Castro, C. Marcocci, R. Rizzoli, C.T. Sempos, J.P. Bilezikian, Consensus statement from 2nd International Conference on Controversies in Vitamin D. Rev. Endocr. Metab. Disord. 21, 89–116 (2020). https://doi.org/10.1007/s11154-019-09532-w.
doi: 10.1007/s11154-019-09532-w.
A. Giustina, R. Bouillon, N. Binkley, C. Sempos, R.A. Adler, J. Bollerslev, B. Dawson-Hughes, P.R. Ebeling, D. Feldman, A. Heijboer, G. Jones, C.S. Kovacs, M. Lazaretti-Castro, P. Lips, C. Marcocci, S. Minisola, N. Napoli, R. Rizzoli, R. Scragg, J.H. White, A.M. Formenti, J.P. Bilezikian, Controversies in Vitamin D: a statement from the third international conference. JBMR 4, e10417 (2020). https://doi.org/10.1002/jbm4.10417
doi: 10.1002/jbm4.10417
J.P. Bilezikian, A.M. Formenti, R.A. Adler, N. Binkley, R. Bouillon, M. Lazaretti-Castro, C. Marcocci, N. Napoli, R. Rizzoli, A. Giustina, Vitamin D: dosing, levels, form, and route of administration: does one approach fit all. Rev. Endocr. Metab. Disord. 22, 1201–1218 (2021). https://doi.org/10.1007/s11154-021-09693-7
doi: 10.1007/s11154-021-09693-7
J. MacLaughlin, M.F. Holick, Aging decreases the capacity of human skin to produce vitamin D3. J. Clin. Invest 76, 1536–1538 (1985)
doi: 10.1172/JCI112134
M.F. Holick, T.C. Chen, Z. Lu, E. Sauter, Vitamin D and skin physiology: a D-lightful story. J. Bone Miner. Res. 22, V28–V33 (2007)
doi: 10.1359/jbmr.07s211
J.R. Chalcraft, L.M. Cardinal, P.J. Wechsler, B.W. Hollis, K.G. Gerow, B.M. Alexander, J.F. Keith, D.E. Larson-Meyer, Vitamin D synthesis following a single bout of sun exposure in older and younger men and women. Nutrients 12, 2237 (2020). https://doi.org/10.3390/nu12082237
doi: 10.3390/nu12082237
P. Lips, Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr. Rev. 22, 477–501 (2001)
doi: 10.1210/edrv.22.4.0437
R.T. de Jongh, N.M. van Schoor, P. Lips, Changes in vitamin D endocrinology during aging in adults. Mol. Cell. Endocrinol. 453, 144–150 (2017)
doi: 10.1016/j.mce.2017.06.005
V.G. Chel, M.E. Ooms, C. Popp-Snijders, S. Pavel, A.A. Schothorst, C.C. Meulemans, P. Lips, Ultraviolet irradiation corrects vitamin D deficiency and suppresses secondary hyperparathyroidism in the elderly. J. Bone Miner. Res. 13, 1238–1242 (1998)
doi: 10.1359/jbmr.1998.13.8.1238
V.G. Chel, M.E. Ooms, S. Pavel, F. de Gruijl, A. Brand, P. Lips, Prevention and treatment of vitamin D deficiency in Dutch psychogeriatric nursing home residents by weekly half-body UVB exposure after showering: a pilot study. Age Ageing 40, 211–124 (2011)
doi: 10.1093/ageing/afq159
S.E. Mousavi, H. Amini, P. Heydarpour, F. Amini Chermahini, L. Godderis, Air pollution, environmental chemicals, and smoking may trigger vitamin D deficiency: Evidence and potential mechanisms. Environ. Int. 122, 67–90 (2019)
doi: 10.1016/j.envint.2018.11.052
T. Passeron, R. Bouillon, V. Callender, T. Cestari, T.L. Diepgen, A.C. Green, J.C. van der Pols, B.A. Bernard, F. Ly, F. Bernerd, L. Marrot, M. Nielsen, M. Verschoore, N.G. Jablonski, A.R. Young, Sunscreen photoprotection and vitamin D status. Br. J. Dermatol. 181, 916–931 (2019). https://doi.org/10.1111/bjd.17992
doi: 10.1111/bjd.17992
E. Cutillas-Marco, A. Fuertes-Prosper, W.B. Grant, M. Morales-Suarez-Varela, Vitamin D deficiency in South Europe: effect of smoking and aging. Photodermatol. Photoimmunol. Photomed. 28, 159–161 (2012)
doi: 10.1111/j.1600-0781.2012.00649.x
M.B. Snijder, R.M. van Dam, M. Visser, D.J. Deeg, J.M. Dekker, L.M. Bouter, J.C. Seidell, P. Lips, Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J. Clin. Endocrinol. Metab. 90, 4119–4123 (2005)
doi: 10.1210/jc.2005-0216
NCD Risk Factor Collaboration (NCD-RisC), Rising rural body-mass index is the main driver of the global obesity epidemic in adults. Nature 569, 260–264 (2019). https://doi.org/10.1038/s41586-019-1171-x
doi: 10.1038/s41586-019-1171-x
I. Reinders, N.M. van Schoor, D.J.H. Deeg, M. Huisman, M. Visser, Trends in lifestyle among three cohorts of adults aged 55-64 years in 1992/1993, 2002/2003 and 2012/2013. Eur. J. Public Health 28, 564–570 (2018). https://doi.org/10.1093/eurpub/ckx173
doi: 10.1093/eurpub/ckx173
R.M. van Dam, M.B. Snijder, J.M. Dekker, C.D. Stehouwer, L.M. Bouter, R.J. Heine, P. Lips, Potentially modifiable determinants of vitamin D status in an older population in the Netherlands: the Hoorn Study. Am. J. Clin. Nutr. 85, 755–761 (2007). https://doi.org/10.1093/ajcn/85.3.755
doi: 10.1093/ajcn/85.3.755
E.G. van den Heuvel, N. van Schoor, R.T. de Jongh, M. Visser, P. Lips, Cross-sectional study on different characteristics of physical activity as determinants of vitamin D status; inadequate in half of the population. Eur. J. Clin. Nutr. 67, 360–365 (2013)
doi: 10.1038/ejcn.2013.22
M.S. Vallejo, J.E. Blümel, E. Arteaga, S. Aedo, V. Tapia, A. Araos, C. Sciaraffia, C. Castelo-Branco, Gender differences in the prevalence of vitamin D deficiency in a southern Latin American country: a pilot study. Climacteric 23, 410–416 (2020). https://doi.org/10.1080/13697137.2020.1752171
doi: 10.1080/13697137.2020.1752171
D.K. Sanghera, B.R. Sapkota, C.E. Aston, P.R. Blackett, Vitamin D status, gender differences, and cardiometabolic health disparities. Ann. Nutr. Metab. 70, 79–87 (2017). https://doi.org/10.1159/000458765
doi: 10.1159/000458765
Z. Wu, C.A. Camargo Jr., I.R. Reid, A. Beros, J.D. Sluyter, D. Waayer, C.M.M. Lawes, L. Toop, K.T. Khaw, R. Scragg, What factors modify the effect of monthly bolus dose vitamin D supplementation on 25-hydroxyvitamin D concentrations. ? J. Steroid. Biochem. Mol. Biol. 201, 105687 (2020). https://doi.org/10.1016/j.jsbmb.2020.105687
M.C. Chapuy, M.E. Arlot, F. Duboeuf, J. Brun, B. Crouzet, S. Arnaud, P.D. Delmas, P.J. Meunier, Vitamin D3 and calcium to prevent hip fractures in elderly women. N. Engl. J. Med. 327, 1637–1642 (1992)
doi: 10.1056/NEJM199212033272305
P. Lips, M.C. Chapuy, B. Dawson-Hughes, H.A. Pols, M.F. Holick, An international comparison of serum 25-hydroxyvitamin D measurements. Osteoporos. Int. 9, 394–397 (1999). https://doi.org/10.1007/s001980050162
doi: 10.1007/s001980050162
P. Lips, T. Duong, A. Oleksik, D. Black, S. Cummings, D. Cox, T. Nickelsen, A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J. Clin. Endocrinol. Metab. 86, 1212–1221 (2001). https://doi.org/10.1210/jcem.86.3.7327
doi: 10.1210/jcem.86.3.7327
E. Sohl, R.T. de Jongh, M.W. Heymans, N.M. van Schoor, P. Lips, Thresholds for serum 25(OH)D concentrations with respect to different outcomes. J. Clin. Endocrinol. Metab. 100, 2480–2488 (2015). https://doi.org/10.1210/jc.2015-1353
doi: 10.1210/jc.2015-1353
N.O. Kuchuk, N.M. van Schoor, S.M. Pluijm, A. Chines, P. Lips, Vitamin D status, parathyroid function, bone turnover, and BMD in postmenopausal women with osteoporosis: global perspective. J. Bone Miner. Res. 24, 693–701 (2009)
doi: 10.1359/jbmr.081209
I.R. Reid, A.M. Horne, B. Mihov, G.D. Gamble, F. Al-Abuwsi, M. Singh, L. Taylor, S. Fenwick, C.A. Camargo, A.W. Stewart, R. Scragg, Effect of monthly high-dose vitamin D on bone density in community-dwelling older adults substudy of a randomized controlled trial. J. Intern. Med. 282, 452–460 (2017). https://doi.org/10.1111/joim.12651
doi: 10.1111/joim.12651
K.T. Khaw, A.W. Stewart, D. Waayer, C.M.M. Lawes, L. Toop, C.A. Camargo Jr., R. Scragg, Effect of monthly high-dose vitamin D supplementation on falls and non-vertebral fractures: secondary and post-hoc outcomes from the randomised, double-blind, placebo-controlled ViDA trial. Lancet Diabetes Endocrinol. 5, 438–447 (2017). https://doi.org/10.1016/S2213-8587(17)30103-1
doi: 10.1016/S2213-8587(17)30103-1
H.M. Macdonald, I.R. Reid, G.D. Gamble, W.D. Fraser, J.C. Tang, A.D. Wood, 25-Hydroxyvitamin D threshold for the effects of vitamin D supplements on bone density: secondary analysis of a randomized controlled trial. J. Bone Miner. Res. 33, 1464–1469 (2018)
doi: 10.1002/jbmr.3442
N.A. de França, M.B. Camargo, M. Lazaretti-Castro, B.S. Peters, L.A. Martini, Dietary patterns and bone mineral density in Brazilian postmenopausal women with osteoporosis: a cross-sectional study. Eur. J. Clin. Nutr. 70, 85–90 (2016). https://doi.org/10.1038/ejcn.2015.27
doi: 10.1038/ejcn.2015.27
P. Lips, F.C. van Ginkel, M.J. Jongen, F. Rubertus, W.J. van der Vijgh, J.C. Netelenbos, Determinants of vitamin D status in patients with hip fracture and in elderly control subjects. Am. J. Clin. Nutr. 46, 1005–1010 (1987). https://doi.org/10.1093/ajcn/46.6.1005
doi: 10.1093/ajcn/46.6.1005
J.L. Buttriss, S.A. Lanham-New, S. Steenson, L. Levy, G.E. Swan, A.L. Darling, K.D. Cashman, R.E. Allen, L.R. Durrant, C.P. Smith, P. Magee, T.R. Hill, S. Uday, M. Kiely, G. Delamare, A.E. Hoyland, L. Larsen, L.N. Street, J.C. Mathers, A. Prentice, Implementation strategies for improving vitamin D status and increasing vitamin D intake in the UK: current controversies and future perspectives: proceedings of the 2nd Rank Prize Funds Forum on vitamin D. Br. J. Nutr. 127, 1567–1587 (2022). https://doi.org/10.1017/S0007114521002555
doi: 10.1017/S0007114521002555
E.M. Balk, G.P. Adam, V.N. Langberg, A. Earley, P. Clark, P.R. Ebeling, A. Mithal, R. Rizzoli, C.A.F. Zerbini, D.D. Pierroz, B. Dawson-Hughes, International Osteoporosis Foundation Calcium Steering Committee.: Global dietary calcium intake among adults: a systematic review. Osteoporos. Int. 28, 3315–3324 (2017). https://doi.org/10.1007/s00198-017-4230-x
doi: 10.1007/s00198-017-4230-x
C.M. Weaver, D.D. Alexander, C.J. Boushey, B. Dawson-Hughes, J.M. Lappe, M.S. LeBoff, S. Liu, A.C. Looker, T.C. Wallace, D.D. Wang, Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation. Osteoporos. Int. 27, 367–376 (2016). https://doi.org/10.1007/s00198-015-3386-5
doi: 10.1007/s00198-015-3386-5
A. Avenell, J.C. Mcak, D. O’Connell, Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men. Cochrane Database Syst. Rev. 4, CD000227 (2014)
P. Yao, D. Bennett, M. Mafham, X. Lin, Z. Chen, J. Armitage, R. Clarke, Vitamin D and calcium for the prevention of fracture: a systematic review and meta-analysis. JAMA Netw. Open 2, e1917789 (2019). https://doi.org/10.1001/jamanetworkopen.2019.17789
doi: 10.1001/jamanetworkopen.2019.17789
M. Waterhouse, E. Sanguineti, C. Baxter, B. Duarte Romero, D.S.A. McLeod, D.R. English, B.K. Armstrong, P.R. Ebeling, G. Hartel, M.G. Kimlin, R.L. O’Connell, H. Pham, J.C. van der Pols, A.J. Venn, P.M. Webb, D.C. Whiteman, R.E. Neale, Vitamin D supplementation and risk of falling: outcomes from the randomized, placebo-controlled D-Health trial. J. Cachexia Sarcopenia Muscle 12, 1428–1439 (2021). https://doi.org/10.1002/jcsm.12759
doi: 10.1002/jcsm.12759
H.A. Bischoff-Ferrari, B. Dawson-Hughes, E.J. Orav, H.B. Staehelin, O.W. Meyer, R. Theiler, W. Dick, W.C. Willett, A. Egli, Monthly high-dose vitamin D treatment for the prevention of functional decline: a randomized clinical trial. JAMA Intern. Med. 176, 175–183 (2016). https://doi.org/10.1001/jamainternmed.2015.7148
doi: 10.1001/jamainternmed.2015.7148
L.S. Bislev, D. Grove-Laugesen, L. Rejnmark, Vitamin D and muscle health: a systematic review and meta-analysis of randomized placebo-controlled trials. J. Bone Miner. Res. 36, 1651–1660 (2021). https://doi.org/10.1002/jbmr.4412
doi: 10.1002/jbmr.4412
H.A. Bischoff-Ferrari, B. Dawson-Hughes, H.B. Staehelin, J.E. Orav, A.E. Stuck, R. Theiler, J.B. Wong, A. Egli, D.P. Kiel, J. Henschkowski, Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 339, b3692 (2009). https://doi.org/10.1136/bmj.b3692
doi: 10.1136/bmj.b3692
K.M. Sanders, A.L. Stuart, E.J. Williamson, J.A. Simpson, M.A. Kotowicz, D. Young, G.C. Nicholson, Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 303, 1815–1822 (2010). https://doi.org/10.1001/jama.2010.594
doi: 10.1001/jama.2010.594
L.M. Smith, J.C. Gallagher, C. Suiter, Medium doses of daily vitamin D decrease falls and higher doses of daily vitamin D3 increase falls: a randomized clinical trial. J. Steroid Biochem. Mol. Biol. 173, 317–322 (2017). https://doi.org/10.1016/j.jsbmb.2017.03.015
doi: 10.1016/j.jsbmb.2017.03.015
I. Endo, D. Inoue, T. Mitsui, Y. Umaki, M. Akaike, T. Yoshizawa, S. Kato, T. Matsumoto, Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology 144, 5138–5144 (2003). https://doi.org/10.1210/en.2003-0502
doi: 10.1210/en.2003-0502
C. Beaudart, F. Buckinx, V. Rabenda, S. Gillain, E. Cavalier, J. Slomian, J. Petermans, J.Y. Reginster, O. Bruyère, The effects of vitamin D on skeletal muscle strength, muscle mass, and muscle power: a systematic review and meta-analysis of randomized controlled trials. J. Clin. Endocrinol. Metab. 99, 4336–4345 (2014). https://doi.org/10.1210/jc.2014-1742
doi: 10.1210/jc.2014-1742
A.J. Garber, Effects of parathyroid hormone on skeletal muscle protein and amino acid metabolism in the rat. J. Clin. Invest. 71, 1806–1821 (1983). https://doi.org/10.1172/jci110936
doi: 10.1172/jci110936
B.M. Patten, J.P. Bilezikian, L.E. Mallette, A. Prince, W.K. Engel, G.D. Aurbach, Neuromuscular disease in primary hyperparathyroidism. Ann. Intern. Med. 80, 182–193 (1974). https://doi.org/10.7326/0003-4819-80-2-182
doi: 10.7326/0003-4819-80-2-182
C. Joborn, H. Joborn, J. Rastad, G. Akerström, S. Ljunghall, Maximal isokinetic muscle strength in patients with primary hyperparathyroidism before and after parathyroid surgery. Br. J. Surg. 75, 77–80 (1988). https://doi.org/10.1002/bjs.1800750128
doi: 10.1002/bjs.1800750128
L.S. Bislev, L. Langagergaard Rødbro, T. Sikjær, L. Rejnmark, Effects of elevated parathyroid hormone levels on muscle health, postural stability and quality of life in vitamin D-insufficient healthy women: a cross-sectional study. Calcif. Tissue Int. 105, 642–650 (2019). https://doi.org/10.1007/s00223-019-00612-2
doi: 10.1007/s00223-019-00612-2
M.S. Stein, J.D. Wark, S.C. Scherer, S.L. Walton, P. Chick, M.D. Carlantonio, J.D. Zajac, L. Flicker, Falls relate to vitamin D and parathyroid hormone in an Australian nursing home and hostel. JAGS 47, 1195–1201 (1999)
doi: 10.1111/j.1532-5415.1999.tb05199.x
P.N. Sambrook, J.S. Chen, L.M. March, I.D. Cameron, R.G. Cumming, S.R. Lord, J. Schwarz, M.J. Seibel, Serum parathyroid hormone is associated with increased mortality independent of 25-hydroxy vitamin d status, bone mass, and renal function in the frail and very old: a cohort study. J. Clin. Endocrinol. Metab. 89, 5477–5481 (2004). https://doi.org/10.1210/jc.2004-0307
doi: 10.1210/jc.2004-0307
S. Pilz, K. Kienreich, A. Tomaschitz, E. Lerchbaum, A. Meinitzer, W. März, A. Zittermann, J.M. Dekker, Vitamin D and cardiovascular disease: update and outlook. Scand. J. Clin. Lab. Invest. Suppl. 243, 83–91 (2012). https://doi.org/10.3109/00365513.2012.681972
doi: 10.3109/00365513.2012.681972
R. Scragg, The Vitamin D assessment (ViDA) study – design and main findings. J. Steroid Biochem. Mol. Biol. 198, 105562 (2020). https://doi.org/10.1016/j.jsbmb.2019.105562
doi: 10.1016/j.jsbmb.2019.105562
J.E. Manson, S.S. Bassuk, N.R. Cook, I.M. Lee, S. Mora, C.M. Albert, J.E. Buring; VITAL Research Group, Vitamin D, Marine n-3 fatty acids, and primary prevention of cardiovascular disease current evidence. Circ. Res. 126, 112–128 (2020). https://doi.org/10.1161/CIRCRESAHA.119.314541
doi: 10.1161/CIRCRESAHA.119.314541
J.D. Sluyter, C.A. Camargo Jr., A.W. Stewart, D. Waayer, C.M.M. Lawes, L. Toop, K.T. Khaw, S.A.M. Thom, B. Hametner, S. Wassertheurer, K.H. Parker, A.D. Hughes, R. Scragg, Effect of monthly, high-dose, long-term vitamin D supplementation on central blood pressure parameters: A randomized controlled trial substudy. J. Am. Heart Assoc. 6, e006802 (2017). https://doi.org/10.1161/JAHA.117.006802
doi: 10.1161/JAHA.117.006802
D. Manousaki, L.E. Mokry, S. Ross, D. Goltzman, J.B. Richards, Mendelian randomization studies do not support a role for vitamin D in coronary artery disease. Circ. Cardiovasc. Genet. 9, 349–356 (2016). https://doi.org/10.1161/CIRCGENETICS.116.001396
doi: 10.1161/CIRCGENETICS.116.001396
P. Brøndum-Jacobsen, M. Benn, S. Afzal, B.G. Nordestgaard, No evidence that genetically reduced 25-hydroxyvitamin D is associated with increased risk of ischaemic heart disease or myocardial infarction: a Mendelian randomization study. Int. J. Epidemiol. 44, 651–661 (2015). https://doi.org/10.1093/ije/dyv078
doi: 10.1093/ije/dyv078
K.S. Vimaleswaran, A. Cavadino, D.J. Berry; LifeLines Cohort Study investigators, R. Jorde, A.K. Dieffenbach, C. Lu, A.C. Alves, H.J. Heerspink, E. Tikkanen, J. Eriksson, A. Wong, M. Mangino, K.A. Jablonski, I.M. Nolte, D.K. Houston, T.S. Ahluwalia, P.J. van der Most, D. Pasko, L. Zgaga, E. Thiering, V. Vitart, R.M. Fraser, J.E. Huffman, R.A. de Boer, B. Schöttker, K.U. Saum, M.I. McCarthy, J. Dupuis, K.H. Herzig, S. Sebert, A. Pouta, J. Laitinen, M.E. Kleber, G. Navis, M. Lorentzon, K. Jameson, N. Arden, J.A. Cooper, J. Acharya, R. Hardy, O. Raitakari, S. Ripatti, L.K. Billings, J. Lahti, C. Osmond, B.W. Penninx, L. Rejnmark, K.K. Lohman, L. Paternoster, R.P. Stolk, D.G. Hernandez, L. Byberg, E. Hagström, H. Melhus, E. Ingelsson, D. Mellström, O. Ljunggren, I. Tzoulaki, S. McLachlan, E. Theodoratou, C.M. Tiesler, A. Jula, P. Navarro, A.F. Wright, O. Polasek; International Consortium for Blood Pressure (ICBP); Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium; Global Blood Pressure Genetics (Global BPGen) consortium, Caroline Hayward, J.F. Wilson, I. Rudan, V. Salomaa, J. Heinrich, H. Campbell, J.F. Price, M. Karlsson, L. Lind, K. Michaëlsson, S. Bandinelli, T.M. Frayling, C.A. Hartman, T.I. Sørensen, S.B. Kritchevsky, B.L. Langdahl, J.G. Eriksson, J.C. Florez, T.D. Spector, T. Lehtimäki, D. Kuh, S.E. Humphries, C. Cooper, C. Ohlsson, W. März, M.H. de Borst, M. Kumari, M. Kivimaki, T.J. Wang, C. Power, H. Brenner, G. Grimnes, P. van der Harst, H. Snieder, A.D. Hingorani, S. Pilz, J.C. Whittaker, M.R. Järvelin, E. Hyppönen, Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study. Lancet Diabetes Endocrinol. 2, 719–729 (2014). https://doi.org/10.1016/S2213-8587(14)70113-5
doi: 10.1016/S2213-8587(14)70113-5
T. Skaaby, L.L. Husemoen, T. Martinussen, J.P. Thyssen, M. Melgaard, B.H. Thuesen, C. Pisinger, T. Jørgensen, J.D. Johansen, T. Menné, B. Carlsen, P.B. Szecsi, S. Stender, R.V. Fenger, M. Fenger, A. Linneberg, Vitamin D status, filaggrin genotype, and cardiovascular risk factors: a Mendelian randomization approach. PLoS One 8, e57647 (2013). https://doi.org/10.1371/journal.pone.0057647
doi: 10.1371/journal.pone.0057647
Emerging Risk Factors Collaboration/EPIC-CVD/Vitamin D Studies Collaboration., Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses. Lancet Diabetes Endocrinol. 9, 837–846 (2021). https://doi.org/10.1016/S2213-8587(21)00263-1
doi: 10.1016/S2213-8587(21)00263-1
R.E. Neale, C. Baxter, B.D. Romero, D.S.A. McLeod, D.R. English, B.K. Armstrong, P.R. Ebeling, G. Hartel, M.G. Kimlin, R. O’Connell, J.C. van der Pols, A.J. Venn, P.M. Webb, D.C. Whiteman, M. Waterhouse, The D-Health Trial: a randomised controlled trial of the effect of vitamin D on mortality. Lancet Diabetes Endocrinol. 10, 120–128 (2022). https://doi.org/10.1016/S2213-8587(21)00345-4
doi: 10.1016/S2213-8587(21)00345-4
A.G. Pittas, B. Dawson-Hughes, P. Sheehan, J.H. Ware, W.C. Knowler, V.R. Aroda, I. Brodsky, L. Ceglia, C. Chadha, R. Chatterjee, C. Desouza, R. Dolor, J. Foreyt, P. Fuss, A. Ghazi, D.S. Hsia, K.C. Johnson, S.R. Kashyap, S. Kim, E.S. LeBlanc, M.R. Lewis, E. Liao, L.M. Neff, J. Nelson, P. O’Neil, J. Park, A. Peters, L.S. Phillips, R. Pratley, P. Raskin, N. Rasouli, D. Robbins, C. Rosen, E.M. Vickery, M. Staten, D2d Research Group.: Vitamin D supplementation and prevention of type 2 diabetes. N. Engl. J. Med. 381, 520–530 (2019). https://doi.org/10.1056/NEJMoa1900906
doi: 10.1056/NEJMoa1900906
B. Dawson-Hughes, M.A. Staten, W.C. Knowler, J. Nelson, E.M. Vickery, E.S. LeBlanc, L.M. Neff, J. Park, A.G. Pittas; D2d Research Group., Intratrial exposure to vitamin D and new-onset diabetes among adults with prediabetes: a secondary analysis from the vitamin D and type 2 diabetes (D2d) study. Diabetes Care. 43, 2916–2922 (2020). https://doi.org/10.2337/dc20-1765
doi: 10.2337/dc20-1765
R. Jorde, S.T. Sollid, J. Svartberg, H. Schirmer, R.M. Joakimsen, I. Njølstad, O.M. Fuskevåg, Y. Figenschau, M.Y. Hutchinson, Vitamin D 20,000 IU per week for five years does not prevent progression from prediabetes to diabetes. J. Clin. Endocrinol. Metab. 101, 1647–1655 (2016). https://doi.org/10.1210/jc.2015-4013
doi: 10.1210/jc.2015-4013
T. Kawahara, G. Suzuki, T. Inazu, S. Mizuno, F. Kasagi, Y. Okada, Y. Tanaka, Rationale and design of Diabetes prevention with active Vitamin D (DPVD): a randomised, double-blind, placebo-controlled study. BMJ Open 6, e011183 (2016). https://doi.org/10.1136/bmjopen-2016-011183
doi: 10.1136/bmjopen-2016-011183
Kawahara. T.: Eldecalcitol, a vitamin D analogue, for diabetes prevention in impaired glucose tolerance (DPVD study). Diabetes Care. 67 (2018).
A.G. Pittas, R. Jorde, T. Kawahara, B. Dawson-Hughes, Vitamin D supplementation for prevention of type 2 diabetes mellitus: To d or not to D. ? J. Clin. Endocrinol. Metab. 105, 3721–3733 (2020). https://doi.org/10.1210/clinem/dgaa594
M. Barbarawi, Y. Zayed, O. Barbarawi, A. Bala, A. Alabdouh, I. Gakhal, F. Rizk, M. Alkasasbeh, G. Bachuwa, J.E. Manson, Effect of vitamin D supplementation on the incidence of diabetes mellitus. J. Clin. Endocrinol. Metab. 105, dgaa335 (2020). https://doi.org/10.1210/clinem/dgaa335
doi: 10.1210/clinem/dgaa335
Y. Zhang, H. Tan, J. Tang, J. Li, W. Chong, Y. Hai, Y. Feng, L.D. Lunsford, P. Xu, D. Jia, F. Fang, Effects of vitamin D supplementation on prevention of type 2 diabetes in patients with prediabetes: A systematic review and meta-analysis. Diabetes Care. 43, 1650–1658 (2020). https://doi.org/10.2337/dc19-1708
doi: 10.2337/dc19-1708
L.H. Matsuo, S.C. Confortin, G. Ceolin, C. Soar, A.J. Xavier, E. D’Orsi, J.D. Moreira, Association between lower serum vitamin D (25-hydroxy-cholecalciferol) concentrations and cognitive impairment in older adults: data from a populational-based cohort study in a middle-income country. Public Health Nutr. 25, 2507–2516 (2022). https://doi.org/10.1017/S1368980021004407
doi: 10.1017/S1368980021004407
B. Arosio, P.D. Rossi, E. Ferri, M. Cesari, G. Vitale, Characterization of Vitamin D status in older persons with cognitive impairment. Nutrients 14, 1142 (2022). https://doi.org/10.3390/nu14061142
doi: 10.3390/nu14061142
G. Bivona, B. Lo Sasso, C.M. Gambino, R.V. Giglio, C. Scazzone, L. Agnello, M. Ciaccio, The role of vitamin D as a biomarker in alzheimer’s disease. Brain Sci. 11, 334 (2021). https://doi.org/10.3390/brainsci11030334
doi: 10.3390/brainsci11030334
L. Perez, L. Heim, A. Sherzai, K. Jaceldo-Siegl, Nutrition and vascular dementia. J. Nutr. Health Aging 16, 319–324 (2012). https://doi.org/10.1007/s12603-012-0042-z
doi: 10.1007/s12603-012-0042-z
J. Hu, J. Jia, Y. Zhang, R. Miao, X. Huo, F. Ma, Effects of vitamin D3 supplementation on cognition and blood lipids: a 12-month randomised, double-blind, placebo-controlled trial. J. Neurol. Neurosurg. Psychiatry 89, 1341–1347 (2018). https://doi.org/10.1136/jnnp-2018-318594
doi: 10.1136/jnnp-2018-318594
J. Jia, J. Hu, X. Huo, R. Miao, Y. Zhang, F. Ma, Effects of vitamin D supplementation on cognitive function and blood Aβ-related biomarkers in older adults with Alzheimer’s disease: a randomised, double-blind, placebo-controlled trial. J. Neurol. Neurosurg. Psychiatry 90, 1347–1352 (2019). https://doi.org/10.1136/jnnp-2018-320199
doi: 10.1136/jnnp-2018-320199
M. Castle, N. Fiedler, L.C. Pop, S.J. Schneider, Y. Schlussel, D. Sukumar, L. Hao, S.A. Shapses, Three doses of vitamin d and cognitive outcomes in older women: a double-blind randomized controlled trial. J. Gerontol. A. Biol. Sci. Med. Sci. 75, 835–842 (2020). https://doi.org/10.1093/gerona/glz041.
doi: 10.1093/gerona/glz041.
T. Yang, H. Wang, Y. Xiong, C. Chen, K. Duan, J. Jia, F. Ma, Vitamin D supplementation improves cognitive function through reducing oxidative stress regulated by telomere length in older adults with mild cognitive impairment: a 12-month randomized controlled trial. J. Alzheimers Dis. 78, 1509–1518 (2020). https://doi.org/10.3233/JAD-200926
doi: 10.3233/JAD-200926
R. Bouillon, D. Manousaki, C. Rosen, K. Trajanoska, F. Rivadeneira, J.B. Richards, The health effects of vitamin D supplementation: evidence from human studies. Nat. Rev. Endocrinol. 18, 96–110 (2022). https://doi.org/10.1038/s41574-021-00593-z
doi: 10.1038/s41574-021-00593-z
M.J. Barysch, G.F. Hofbauer, R. Dummer, Vitamin D, ultraviolet exposure, and skin cancer in the elderly. Gerontology 56, 410–413 (2010). https://doi.org/10.1159/000315119
doi: 10.1159/000315119
S.S. Maeda, I.S. Kunii, L.F. Hayashi, M. Lazaretti-Castro, Increases in summer serum 25-hydroxyvitamin D (25OHD) concentrations in elderly subjects in São Paulo, Brazil vary with age, gender and ethnicity. BMC Endocr. Disord. 10, 12 (2010). https://doi.org/10.1186/1472-6823-10-12
doi: 10.1186/1472-6823-10-12
M. Samefors, A. Tengblad, C.J. Östgren, Sunlight exposure and vitamin D levels in older people- an intervention study in Swedish nursing homes. J. Nutr. Health Aging 24, 1047–1052 (2020). https://doi.org/10.1007/s12603-020-1435-z
doi: 10.1007/s12603-020-1435-z
P.N. Sambrook, I.D. Cameron, J.S. Chen, R.G. Cumming, S. Durvasula, M. Herrmann, C. Kok, S.R. Lord, M. Macara, L.M. March, R.S. Mason, M.J. Seibel, N. Wilson, J.M. Simpson, Does increased sunlight exposure work as a strategy to improve vitamin D status in the elderly: a cluster randomised controlled trial. Osteoporos. Int. 23, 615–624 (2012). https://doi.org/10.1007/s00198-011-1590-5
doi: 10.1007/s00198-011-1590-5
M.M. Pinheiro, N.J. Schuch, P.S. Genaro, R.M. Ciconelli, M.B. Ferraz, L.A. Martini, Nutrient intakes related to osteoporotic fractures in men and women–the Brazilian Osteoporosis Study (BRAZOS). Nutr. J. 8, 6 (2009). https://doi.org/10.1186/1475-2891-8-6
doi: 10.1186/1475-2891-8-6
J.L. Buttriss, S.A. Lanham-New, Is a vitamin D fortification strategy needed? Nutr. Bull. 45, 115–122 (2020). https://doi.org/10.1111/nbu.12430
doi: 10.1111/nbu.12430
P. Lips, K.D. Cashman, C. Lamberg-Allardt, H.A. Bischoff-Ferrari, B. Obermayer-Pietsch, M.L. Bianchi, J. Stepan, G. El-Hajj Fuleihan, R. Bouillon, Current vitamin D status in European and Middle East countries and strategies to prevent vitamin D deficiency: a position statement of the European Calcified Tissue Society. Eur. J. Endocrinol. 180, P23–P54 (2019). https://doi.org/10.1530/EJE-18-0736
doi: 10.1530/EJE-18-0736
K.D. Cashman, Vitamin D Deficiency: defining, prevalence, causes, and strategies of addressing. Calcif. Tissue Int. 106, 14–29 (2020). https://doi.org/10.1007/s00223-019-00559-4
doi: 10.1007/s00223-019-00559-4
T. Jääskeläinen, S.T. Itkonen, A. Lundqvist, M. Erkkola, T. Koskela, K. Lakkala, K.G. Dowling, G.L. Hull, H. Kröger, J. Karppinen, E. Kyllönen, T. Härkänen, K.D. Cashman, S. Männistö, C. Lamberg-Allardt, The positive impact of general vitamin D food fortification policy on vitamin D status in a representative adult Finnish population: evidence from an 11-y follow-up based on standardized 25-hydroxyvitamin D data. Am. J. Clin. Nutr. 105, 1512–1520 (2017). https://doi.org/10.3945/ajcn.116.151415
doi: 10.3945/ajcn.116.151415
S. Pilz, A. Zittermann, C. Trummer, V. Theiler-Schwetz, E. Lerchbaum, M.H. Keppel, M.R. Grübler, W. März, M. Pandis, Vitamin D testing and treatment: a narrative review of current evidence. Endocr. Connect. 8, R27–R43 (2019). https://doi.org/10.1530/EC-18-0432
doi: 10.1530/EC-18-0432
K.D. Cashman, C. Ritz, M. Kiely; Odin Collaborators., Improved dietary guidelines for vitamin D: Application of individual participant data (IPD)-level meta-regression analyses. Nutrients 9, 469 (2017). https://doi.org/10.3390/nu9050469
doi: 10.3390/nu9050469
https://www.fda.gov/media/151707/download Accessed 16 Sept 2021
J.P. Bilezikian, D. Bikle, M. Hewison, M. Lazaretti-Castro, A.M. Formenti, A. Gupta, M.V. Madhavan, N. Nair, V. Babalyan, N. Hutchings, N. Napoli, D. Accili, N. Binkley, D.W. Landry, A. Giustina, Mechanisms in endocrinology: Vitamin D and COVID-19. Eur. J. Endocrinol. 183, R133–R147 (2020). https://doi.org/10.1530/EJE-20-0665
doi: 10.1530/EJE-20-0665
L. di Filippo, A. Allora, M. Doga, A.M. Formenti, M. Locatelli, P. Rovere Querini, S. Frara, A. Giustina, Vitamin D levels are associated with blood glucose and BMI in COVID-19 patients, predicting disease severity. J. Clin. Endocrinol. Metab. 107, e348–e360 (2022). https://doi.org/10.1210/clinem/dgab599
doi: 10.1210/clinem/dgab599
E.S. Chambers, M. Vukmanovic-Stejic, C.T. Turner, B.B. Shih, H. Trahair, G. Pollara, E. Tsaliki, M. Rustin, T.C. Freeman, N.A. Mabbott, M. Noursadeghi, A.R. Martineau, A.N. Akbar, Vitamin D3 replacement enhances antigen-specific immunity in older adults. Immunother. Adv. 1, ltaa008 (2021). https://doi.org/10.1093/immadv/ltaa008
doi: 10.1093/immadv/ltaa008
R. Bouillon, J.M. Quesada-Gomez, Vitamin D endocrine system and COVID-19. JBMR 5, e10576 (2021). https://doi.org/10.1002/jbm4.10576
doi: 10.1002/jbm4.10576
F.M. Ulivieri, G. Banfi, V. Camozzi, A. Colao, A.M. Formenti, S. Frara, G. Lombardi, N. Napoli, A. Giustina, Vitamin D in the Covid-19 era: a review with recommendations from a G.I.O.S.E.G. expert panel. Endocrine 72, 597–603 (2021). https://doi.org/10.1007/s12020-021-02749-3
doi: 10.1007/s12020-021-02749-3